Vital Therapies reported $110.9M in Market Capitalization this February of 2023, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Biomarin Pharmaceutical BMRN:US USD 15.72B 392M
Dynavax Technologies DVAX:US USD 1.32B 270M
Enanta Pharmaceuticals ENTA:US USD 968M 107M
Insmed INSM:US USD 2.62B 258M
Intercept Pharmaceuticals ICPT:US USD 574M 164M
Mirati Therapeutics MRTX:US USD 3.88B 156M
Omeros OMER:US USD 198M 25M
Orasure Technologies OSUR:US USD 275M 79M
Quidel QDEL:US USD 4.79B 1.72B
Regulus Therapeutics RGLS:US USD 25M 5M
Revance Therapeutics RVNC:US USD 2.22B 1.22B
Ultragenyx Pharmaceutical RARE:US USD 2.9B 1.27B
United Therapeutics UTHR:US USD 9.53B 1.14B
Vital Therapies VTL:US USD 97M 21M
Xoma XOMA:US USD 205M 50M